BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10534139)

  • 1. A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering.
    Ginsberg H; Plutzky J; Sobel BE
    J Cardiovasc Risk; 1999 Oct; 6(5):337-46. PubMed ID: 10534139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular effects of the thiazolidinedione troglitazone].
    Yamada K; Kuzuya H; Nakano T
    Nihon Rinsho; 2000 Feb; 58(2):435-9. PubMed ID: 10707572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of troglitazone.
    Umland EM; Romanelli AM
    Ann Pharmacother; 1999 Feb; 33(2):229-32. PubMed ID: 10084419
    [No Abstract]   [Full Text] [Related]  

  • 4. LDL cholesterol and troglitazone therapy.
    Howard BV; Howard WJ
    Diabetes Care; 1998 Dec; 21(12):2201-3. PubMed ID: 9839127
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
    Parker JC
    Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone and related compounds: therapeutic potential beyond diabetes.
    Fujiwara T; Horikoshi H
    Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL; Faulds D
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapeutic approaches to reversing insulin resistance.
    Sonnenberg GE; Kotchen TA
    Curr Opin Nephrol Hypertens; 1998 Sep; 7(5):551-5. PubMed ID: 9818203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers.
    Mudaliar S; Henry RR
    Annu Rev Med; 2001; 52():239-57. PubMed ID: 11160777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.
    Inzucchi SE; Maggs DG; Spollett GR; Page SL; Rife FS; Walton V; Shulman GI
    N Engl J Med; 1998 Mar; 338(13):867-72. PubMed ID: 9516221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone. Is it all over?
    Wagenaar LJ; Kuck EM; Hoekstra JB
    Neth J Med; 1999 Jul; 55(1):4-12. PubMed ID: 10431549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drugs for diabetes.
    Tack CJ; Smits P
    Neth J Med; 1999 Nov; 55(5):209-11. PubMed ID: 10593129
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diabetes Prevention Program.
    Muniyappa R; El-Atat F; Aneja A; McFarlane SI
    Curr Diab Rep; 2003 Jun; 3(3):221-2. PubMed ID: 12762969
    [No Abstract]   [Full Text] [Related]  

  • 17. Troglitazone.
    Spencer CM; Markham A
    Drugs; 1997 Jul; 54(1):89-101; discussion 102. PubMed ID: 9211083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troglitazone in type II diabetes mellitus.
    Sparano N; Seaton TL
    Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for and role of thiazolidinediones in type 2 diabetes mellitus.
    Lebovitz HE
    Am J Cardiol; 2002 Sep; 90(5A):34G-41G. PubMed ID: 12231077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.